NAV
$28.96
AUM
$25.0M
Expense Ratio
-
Dividend Yield
0.24%
Beta
1.54
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +0.92% | +16.91% | +22.85% | -6.93% | -5.67% | -12.76% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | DXCM | DexCom Inc | 4.90% |
| 2 | IQV | IQVIA Holdings Inc | 4.72% |
| 3 | OSCR | Oscar Health Inc Class A | 4.61% |
| 4 | GEHC | GE HealthCare Technologies Inc Common Stock | 4.18% |
| 5 | VEEV | Veeva Systems Inc Class A | 4.14% |
| 6 | PHIA.AS | Koninklijke Philips NV | 4.13% |
| 7 | MASI | Masimo Corp | 4.07% |
| 8 | PME.AX | Pro Medicus Ltd | 3.96% |
| 9 | HIMS | Hims & Hers Health Inc Ordinary Shares - Class A | 3.90% |
| 10 | RMD | ResMed Inc | 3.79% |
The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of healthcare technology and the applications thereof, as determined by the index administrator. The principal investment strategy of the fund will be to invest at least 80% of its total assets, plus borrowings for investment purposes (if any), in the securities of the underlying index. The fund is non-diversified.
Inception Date: 2020-07-29